Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors

Tan, Bin; Sacco, Michael; Tan, Haozhou; Li, Kan; Joyce, Ryan; Zhang, Xiujun; Chen, Yu; Wang, Jun

doi:10.1016/j.ejmech.2023.115667

Title: Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors

Journal Article · 31 October 2023 · European Journal of Medicinal Chemistry

DOI: https://doi.org/10.1016/j.ejmech.2023.115667 · OSTI ID:1992972

Tan, Bin; Sacco, Michael; Tan, Haozhou; Li, Kan; Joyce, Ryan; Zhang, Xiujun; Chen, Yu;

Not Available

View Accepted Manuscript (Publisher)

Cite

Export

Save

Sponsoring Organization:: USDOE Office of Science (SC), Biological and Environmental Research (BER)

Grant/Contract Number:: AC02-06CH11357

OSTI ID:: 1992972

Journal Information:: European Journal of Medicinal Chemistry, Journal Name: European Journal of Medicinal Chemistry Journal Issue: C Vol. 259; ISSN 0223-5234

Publisher:: ElsevierCopyright Statement

Country of Publication:: France

Language:: English

References (40)

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial Ader, Florence; Bouscambert-Duchamp, Maude; Hites, Maya The Lancet Infectious Diseases, Vol. 22, Issue 2 https://doi.org/10.1016/S1473-3099(21)00485-0	journal	February 2022
Selective covalent targeting of SARS-CoV-2 main protease by enantiopure chlorofluoroacetamide Yamane, Daiki; Onitsuka, Satsuki; Re, Suyong Chemical Science, Vol. 13, Issue 10 https://doi.org/10.1039/D1SC06596C	journal	January 2022
Neutral red uptake assay for the estimation of cell viability/cytotoxicity Repetto, Guillermo; del Peso, Ana; Zurita, Jorge L. Nature Protocols, Vol. 3, Issue 7 https://doi.org/10.1038/nprot.2008.75	journal	June 2008
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Solidarity Trial Consortium, Who The Lancet, Vol. 399, Issue 10339, p. 1941-1953 https://doi.org/10.1016/S0140-6736(22)00519-0	journal	May 2022
Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors Stille, Julia K.; Tjutrins, Jevgenijs; Wang, Guanyu European Journal of Medicinal Chemistry, Vol. 229 https://doi.org/10.1016/j.ejmech.2021.114046	journal	February 2022
Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir Xia, Zilei; Sacco, Michael; Hu, Yanmei ACS Pharmacology & Translational Science, Vol. 4, Issue 4 https://doi.org/10.1021/acsptsci.1c00099	journal	June 2021
Evolutionary and Structural Insights about Potential SARS-CoV-2 Evasion of Nirmatrelvir Yang, Kai S.; Leeuwon, Sunshine Z.; Xu, Shiqing Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.2c00404	journal	June 2022
Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19 Ghosh, Arun K.; Mishevich, Jennifer L.; Mesecar, Andrew ChemMedChem, Vol. 17, Issue 22 https://doi.org/10.1002/cmdc.202200440	journal	October 2022
REFMAC 5 for the refinement of macromolecular crystal structures Murshudov, Garib N.; Skubák, Pavol; Lebedev, Andrey A. Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4 https://doi.org/10.1107/S0907444911001314	journal	March 2011
Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics Ghosh, Arun K.; Brindisi, Margherita; Shahabi, Dana ChemMedChem, Vol. 15, Issue 11 https://doi.org/10.1002/cmdc.202000223	journal	May 2020
Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors Siklos, Marton; BenAissa, Manel; Thatcher, Gregory R. J. Acta Pharmaceutica Sinica B, Vol. 5, Issue 6 https://doi.org/10.1016/j.apsb.2015.08.001	journal	November 2015
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors Kitamura, Naoya; Sacco, Michael Dominic; Ma, Chunlong Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.1c00509	journal	April 2021
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system Zhou, Yuyong; Gammeltoft, Karen Anbro; Ryberg, Line Abildgaard Science Advances, Vol. 8, Issue 51 https://doi.org/10.1126/sciadv.add7197	journal	December 2022
Characteristics of SARS-CoV-2 and COVID-19 Hu, Ben; Guo, Hua; Zhou, Peng Nature Reviews Microbiology, Vol. 19, Issue 3 https://doi.org/10.1038/s41579-020-00459-7	journal	October 2020
Discovery, Synthesis, And Structure-Based Optimization of a Series of N -( tert -Butyl)-2-( N -arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease Jacobs, Jon; Grum-Tokars, Valerie; Zhou, Ya Journal of Medicinal Chemistry, Vol. 56, Issue 2 https://doi.org/10.1021/jm301580n	journal	January 2013
MOLREP an Automated Program for Molecular Replacement Vagin, A.; Teplyakov, A. Journal of Applied Crystallography, Vol. 30, Issue 6, p. 1022-1025 https://doi.org/10.1107/S0021889897006766	journal	December 1997
SARS-CoV-2 Main Protease Drug Design, Assay Development, and Drug Resistance Studies Tan, Bin; Joyce, Ryan; Tan, Haozhou Accounts of Chemical Research, Vol. 56, Issue 2 https://doi.org/10.1021/acs.accounts.2c00735	journal	December 2022
Exploring the Versatility of the Covalent Thiol–Alkyne Reaction with Substituted Propargyl Warheads: A Deciding Role for the Cysteine Protease Mons, Elma; Kim, Robbert Q.; van Doodewaerd, Bjorn R. Journal of the American Chemical Society, Vol. 143, Issue 17 https://doi.org/10.1021/jacs.0c10513	journal	April 2021
3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents Konno, Sho; Kobayashi, Kiyotaka; Senda, Miki Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.1c00665	journal	July 2021
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology Gehringer, Matthias; Laufer, Stefan A. Journal of Medicinal Chemistry, Vol. 62, Issue 12 https://doi.org/10.1021/acs.jmedchem.8b01153	journal	December 2018
SARS-CoV-2 Antiviral Therapy Tao, Kaiming; Tzou, Philip L.; Nouhin, Janin Clinical Microbiology Reviews, Vol. 34, Issue 4 https://doi.org/10.1128/CMR.00109-21	journal	December 2021
Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity Ma, Chunlong; Xia, Zilei; Sacco, Michael Dominic Journal of the American Chemical Society, Vol. 143, Issue 49 https://doi.org/10.1021/jacs.1c08060	journal	December 2021
Coot model-building tools for molecular graphics Emsley, Paul; Cowtan, Kevin Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132 https://doi.org/10.1107/S0907444904019158	journal	November 2004
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells Zhou, Shuntai; Hill, Collin S.; Sarkar, Sanjay The Journal of Infectious Diseases, Vol. 224, Issue 3 https://doi.org/10.1093/infdis/jiab247	journal	May 2021
Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors Gao, Shenghua; Song, Letian; Claff, Tobias Journal of Medicinal Chemistry, Vol. 65, Issue 24 https://doi.org/10.1021/acs.jmedchem.2c01716	journal	December 2022
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses Hu, Yanmei; Ma, Chunlong; Szeto, Tommy ACS Infectious Diseases, Vol. 7, Issue 3 https://doi.org/10.1021/acsinfecdis.0c00761	journal	March 2021
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease Tan, Haozhou; Hu, Yanmei; Jadhav, Prakash Journal of Medicinal Chemistry, Vol. 65, Issue 11 https://doi.org/10.1021/acs.jmedchem.2c00303	journal	May 2022
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape Tregoning, John S.; Flight, Katie E.; Higham, Sophie L. Nature Reviews Immunology, Vol. 21, Issue 10 https://doi.org/10.1038/s41577-021-00592-1	journal	August 2021
Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir Hu, Yanmei; Lewandowski, Eric M.; Tan, Haozhou ACS Central Science https://doi.org/10.1021/acscentsci.3c00538	journal	July 2023
On Terminal Alkynes That Can React with Active-Site Cysteine Nucleophiles in Proteases Ekkebus, Reggy; van Kasteren, Sander I.; Kulathu, Yogesh Journal of the American Chemical Society, Vol. 135, Issue 8 https://doi.org/10.1021/ja309802n	journal	February 2013
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease Ma, Chunlong; Sacco, Michael Dominic; Hurst, Brett Cell Research, Vol. 30, Issue 8 https://doi.org/10.1038/s41422-020-0356-z	journal	June 2020
Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers Ma, Chunlong; Zhang, Jiantao; Wang, Jun Molecular Pharmacology, Vol. 90, Issue 3 https://doi.org/10.1124/mol.116.105346	journal	July 2016
An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron Quan, Bao-Xue; Shuai, Huiping; Xia, An-Jie Nature Microbiology, Vol. 7, Issue 5 https://doi.org/10.1038/s41564-022-01119-7	journal	April 2022
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M ^pro and cathepsin L Sacco, Michael Dominic; Ma, Chunlong; Lagarias, Panagiotis Science Advances, Vol. 6, Issue 50 https://doi.org/10.1126/sciadv.abe0751	journal	November 2020
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 Hammond, Jennifer; Leister-Tebbe, Heidi; Gardner, Annie New England Journal of Medicine, Vol. 386, Issue 15 https://doi.org/10.1056/NEJMoa2118542	journal	April 2022
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 Boras, Britton; Jones, Rhys M.; Anson, Brandon J. Nature Communications, Vol. 12, Issue 1 https://doi.org/10.1038/s41467-021-26239-2	journal	October 2021
Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 3CL Protease Hirose, Yuya; Shindo, Naoya; Mori, Makiko Journal of Medicinal Chemistry, Vol. 65, Issue 20 https://doi.org/10.1021/acs.jmedchem.2c01081	journal	October 2022
An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19 Owen, Dafydd R.; Allerton, Charlotte M. N.; Anderson, Annaliesa S. Science, Vol. 374, Issue 6575 https://doi.org/10.1126/science.abl4784	journal	December 2021
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir Iketani, Sho; Mohri, Hiroshi; Culbertson, Bruce Nature, Vol. 613, Issue 7944 https://doi.org/10.1038/s41586-022-05514-2	journal	November 2022
Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases Brogi, Simone; Ibba, Roberta; Rossi, Sara Molecules, Vol. 27, Issue 8 https://doi.org/10.3390/molecules27082561	journal	April 2022

Similar Records

A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals

Journal Article · 2022 · European Journal of Medicinal Chemistry · OSTI ID:2422634

Alugubelli, Yugendar R.; Geng, Zhi Zachary; Yang, Kai S.; +15 more

Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease

Journal Article · 2021 · Structure · OSTI ID:1879931

Deshmukh, Maya G.; Ippolito, Joseph A.; Zhang, Chun-Hui; +5 more

Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors

Journal Article · 2021 · RSC Medicinal Chemistry · OSTI ID:1982208

Bai, Bing; Arutyunova, Elena; Khan, Muhammad Bashir; +14 more

Title: Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors

Citation Formats

References (40)

Similar Records

Related Subjects